Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

People with chronic hives should be tested for thyroid autoimmunity to manage their condition better.

PRS injections can improve knee function and reduce pain for up to a year.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Thyroid function affects skin health, with a complex interaction between the two.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The skin produces and responds to thyroid-stimulating hormone, which is controlled by other thyroid-related hormones.

An arthritis drug helped a person with severe hair loss regrow their hair.

Cutaneous gene therapy could become a viable treatment for skin and hair disorders with improved vector development and gene expression control.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

LGD1069 effectively prevents breast tumors in mice without toxicity.